137 related articles for article (PubMed ID: 30778791)
1. Genetic Polymorphisms of CCDC26 rs891835, rs6470745, and rs55705857 in Glioma Risk: A Systematic Review and Meta-analysis.
González-Castro TB; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Genis-Mendoza AD; Pérez-Hernández N; Martínez-Magaña JJ; Rodríguez-Pérez JM
Biochem Genet; 2019 Aug; 57(4):583-605. PubMed ID: 30778791
[TBL] [Abstract][Full Text] [Related]
2. CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population.
Wei XB; Jin TB; Li G; Geng TT; Zhang JY; Chen CP; Gao GD; Chen C; Gong YK
Asian Pac J Cancer Prev; 2014; 15(8):3629-33. PubMed ID: 24870769
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma.
Li S; Jin T; Zhang J; Lou H; Yang B; Li Y; Chen C; Zhang Y
Cancer Epidemiol; 2012 Jun; 36(3):283-7. PubMed ID: 22369735
[TBL] [Abstract][Full Text] [Related]
4. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.
Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M
Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354
[TBL] [Abstract][Full Text] [Related]
5. CCDC26 rs4295627 polymorphism (8q24.21) and glioma risk: a meta-analysis.
Lu HW; Huang M; Wang JH; Sun XL; Ke YQ
Genet Mol Res; 2015 Oct; 14(4):12074-84. PubMed ID: 26505354
[TBL] [Abstract][Full Text] [Related]
6. CCDC26 rs4295627 polymorphisms associated with an increased risk of glioma: A meta-analysis.
Zeng J; Luo Y; Yu M; Li J; Liu Z
Adv Clin Exp Med; 2017 Nov; 26(8):1275-1281. PubMed ID: 29264887
[TBL] [Abstract][Full Text] [Related]
7. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies.
Walsh KM; Anderson E; Hansen HM; Decker PA; Kosel ML; Kollmeyer T; Rice T; Zheng S; Xiao Y; Chang JS; McCoy LS; Bracci PM; Wiemels JL; Pico AR; Smirnov I; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Genet Epidemiol; 2013 Feb; 37(2):222-8. PubMed ID: 23280628
[TBL] [Abstract][Full Text] [Related]
9. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis.
Wu Y; Zhou J; Zhang J; Tang Z; Chen X; Huang L; Liu S; Chen H; Wang Y
Front Oncol; 2023; 13():1180099. PubMed ID: 37746290
[TBL] [Abstract][Full Text] [Related]
10. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
11. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
Xin Y; Hao S; Lu J; Wang Q; Zhang L
PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
[TBL] [Abstract][Full Text] [Related]
12. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis.
Gao X; Mi Y; Yan A; Sha B; Guo N; Hu Z; Zhang N; Jiang F; Gou X
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e13-21. PubMed ID: 24935770
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in N-myc (and STAT) interactor and susceptibility to glioma in a Chinese Han population.
Meng D; Li X; Zhang S; Zhao Y; Song X; Chen Y; Wang S; Mao Y; Chen H; Lu D
Tumour Biol; 2015 Mar; 36(3):1579-88. PubMed ID: 25387807
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.
Zhang J; Yang J; Chen Y; Mao Q; Li S; Xiong W; Lin Y; Chen J; Ge J
Mol Neurobiol; 2016 May; 53(4):2610-8. PubMed ID: 26093379
[TBL] [Abstract][Full Text] [Related]
15. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies.
Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444
[TBL] [Abstract][Full Text] [Related]
16. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
Qian T; Zhang B; Qian C; He Y; Li Y
Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
[TBL] [Abstract][Full Text] [Related]
17. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
18. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
Wibom C; Späth F; Dahlin AM; Langseth H; Hovig E; Rajaraman P; Johannesen TB; Andersson U; Melin B
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):810-6. PubMed ID: 25713050
[TBL] [Abstract][Full Text] [Related]
19. Associations between the rs6010620 polymorphism in RTEL1 and risk of glioma: a meta-analysis of 20,711 participants.
Wu Y; Tong X; Tang LL; Zhou K; Zhong CH; Jiang S
Asian Pac J Cancer Prev; 2014; 15(17):7163-7. PubMed ID: 25227808
[TBL] [Abstract][Full Text] [Related]
20. Association between the XRCC1 Arg194Trp polymorphism and glioma risk: an updated meta-analysis.
Xu C; Chen P; Liu W; Gu AH; Wang XR
Asian Pac J Cancer Prev; 2014; 15(17):7419-24. PubMed ID: 25227852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
